Earlier time to remission predicts sustained clinical remission in early rheumatoid arthritis - Results from the Canadian Early Arthritis Cohort (CATCH)

Journal of Rheumatology

Volumn 41, Issue 11, 2014, Pages 2161-2166

  Kuriya, Bindee ^a,c   Xiong, Juan ^a,c   Boire, Gilles ^b   Haraoui, Boulos ^c   Hitchon, Carol ^d   Pope, Janet ^e   Thorne, John Carter ^f   Tin, Diane ^f   Keystone, Edward C ^a   Bykerk, Vivian ^a,g  

^a UNIVERSITY OF TORONTO   (Canada)

^b UNIVERSITÉ DE SHERBROOKE   (Canada)

^c Institut de Rhumatologie   (Canada)

^d UNIVERSITY OF MANITOBA   (Canada)

^e UNIVERSITY OF WESTERN ONTARIO   (Canada)

^f SOUTHLAKE REGIONAL HEALTH CENTRE   (Canada)

^g Cornell University ^*  (United States)

Author keywords

Disease modifying antirheumatic drugs; Outcomes; Remission; Rheumatoid arthritis

Indexed keywords

C REACTIVE PROTEIN; CORTICOSTEROID; DISEASE MODIFYING ANTIRHEUMATIC DRUG; METHOTREXATE; ANTIRHEUMATIC AGENT;

ADULT; ARTHROPATHY; ARTICLE; DAS28; DISEASE ACTIVITY; DISEASE SEVERITY; ERYTHROCYTE SEDIMENTATION RATE; FATIGUE; FEMALE; HEALTH ASSESSMENT QUESTIONNAIRE; HUMAN; JOINT SWELLING; JOINT TENDERNESS; MAJOR CLINICAL STUDY; MALE; PAIN; PRIORITY JOURNAL; REMISSION; RHEUMATOID ARTHRITIS; SEX DIFFERENCE; SIMPLIFIED DISEASE ACTIVITY INDEX; AGE; AGED; ARTHRITIS, RHEUMATOID; CANADA; COHORT ANALYSIS; EARLY DIAGNOSIS; FACTUAL DATABASE; FOLLOW UP; JOINT CHARACTERISTICS AND FUNCTIONS; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; PHYSIOLOGY; PREDICTIVE VALUE; PROSPECTIVE STUDY; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; TIME; TREATMENT OUTCOME;

ADULT; AGE FACTORS; AGED; ANTIRHEUMATIC AGENTS; ARTHRITIS, RHEUMATOID; CANADA; COHORT STUDIES; DATABASES, FACTUAL; EARLY DIAGNOSIS; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; MULTIVARIATE ANALYSIS; PAIN MEASUREMENT; PREDICTIVE VALUE OF TESTS; PROSPECTIVE STUDIES; RANGE OF MOTION, ARTICULAR; REMISSION INDUCTION; RISK ASSESSMENT; SEVERITY OF ILLNESS INDEX; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84915805853     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.140137     Document Type: Article

References (20)

1. Bykerk VP, Keystone EC, Kuriya B, Larché M, Thome JC, Haraoui B. Achieving remission in clinical practice: lessons from clinical trial data. Clin Exp Rheumatol 2013; 31:621-32.
2. Singh JA, Furst DE, Bharat A, Curtis J.R., Kavanaugh AF, Kremer JM, et al. 2012 update of the 2008 American College of Rheumatology recommendations for the use of disease-modifying antirheumatic drugs and biologic agents in the treatment of rheumatoid arthritis. Arthritis Care Res 2012; 64:625-39.
3. Vermeer M, Kuper HH, Moens H.J., Drossaers-Bakker KW, van der Bijl AE, van Riel PL, et al. Sustained beneficial effects of a protocolized treat-to-target strategy in very early rheumatoid arthritis: three-year results of the Dutch Rheumatoid Arthritis Monitoring Remission Induction Cohort. Arthritis Care Res 2013; 65:1219-26.
4. Lillegraven S, Prince FH, Shadick N.A., Bykerk VP, Lu B, Frits ML, et al. Remission and radiographic outcome in rheumatoid arthritis: application of the 2011 ACR/EULAR remission criteria in an observational cohort. Ann Rheum Dis 2012; 71:681-6.
5. Bathon J, Robles M, Ximenes A.C., Nayiager S., Wollenhaupt J, Durez P, et al. Sustained disease remission and inhibition of radiographic progression in methotrexate-naive patients with rheumatoid arthritis and poor prognostic factors treated with abatacept: 2-year outcomes. Ann Rheum Dis 2011; 70:1949-56.
6. Schipper LG, Fransen J, den Broeder AA, Van Riel PL. Time to achieve remission determines time to be in remission. Arthritis Res Ther 2010; 12:R97.
7. Cannon GW, Wang BC, Park G.S., Koenig A., Collier DH, Keystone EC. Remission in rheumatoid arthritis patients treated with etanercept monotherapy: clinical practice and clinical trial experience. Clin Exp Rheumatol 2013; 31:919-25.
8. Felson DT, Smolen JS, Wells G, Zhang B., van Tuyl LH, Funovits J, et al. American College of Rheumatology /European League Against Rheumatism provisional definition of remission in rheumatoid arthritis for clinical trials. American College of Rheumatology; European League Against Rheumatism. Arthritis Rheum 2011; 63:573-86.
9. Bykerk VP, Jamal S, Boire G., Hitchon CA, Haraoui B, Pope JE, et al. The Canadian Early Arthritis Cohort (CATCH): patients with new-onset synovitis meeting the 2010 ACR/EULAR classification criteria but not the 1987 ACR classification criteria present with less severe disease activity. J Rheumatol 2012; 39:2071-80.
10. Svensson B, Andersson ML, Bala S.V., Forslind K., Hafström I; BARFOT study group. Long-term sustained remission in a cohort study of patients with rheumatoid arthritis: choice of remission criteria. BMJ Open 2013; 3:e003554.
11. van der Woude D, Young A, Jayakumar K, Mertens BJ, Toes RE, van der Heijde D, et al. Prevalence of and predictive factors for sustained disease-modifying antirheumatic drug-free remission in rheumatoid arthritis: results from two large early arthritis cohorts. Arthritis Rheum 2009; 60:2262-71.
12. Ma MH, Ibrahim F, Walker D., Hassell A, Choy EH, Kiely P.D., et al. Remission in early rheumatoid arthritis: predicting treatment response. J Rheumatol 2012; 39:470-5.
13. Jawaheer D, Messing S, Reed G., Ranganath VK, Kremer JM, Louie JS, et al. Significance of sex in achieving sustained remission in the consortium of rheumatology researchers of North America cohort of rheumatoid arthritis patients. Arthritis Care Res 2012; 64:1811-8.
14. Jayakumar K, Norton S, Dixey J., James D, Gough A, Williams P., et al.; Early Rheumatoid Arthritis Study (ERAS). Sustained clinical remission in rheumatoid arthritis: prevalence and prognostic factors in an inception cohort of patients treated with conventional DMARDS. Rheumatology 2012; 51:169-75.
15. Prince FH, Bykerk VP, Shadick N.A., Lu B., Cui J, Frits M, et al. Sustained rheumatoid arthritis remission is uncommon in clinical practice. Arthritis Res Ther 2012; 14:R68.
16. Kuriya B, Sun Y, Boire G., Haraoui B, Hitchon C, Pope J.E., et al. Remission in early rheumatoid arthritis - a comparison of new ACR/EULAR remission criteria to established criteria. J Rheumatol 2012; 39:1155-8.
17. Studenic P, Smolen JS, Aletaha D. Near misses of ACR/EULAR criteria for remission: effects of patient global assessment in Boolean and index-based definitions. Ann Rheum Dis 2012; 71:1702-5.
18. Möttönen T, Hannonen P, Korpela M, Nissilä M, Kautiainen H, Honen J, et al.; FIN-RACo Trial Group. Finnish Rheumatoid Arthritis Combination therapy. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002; 46:894-8.
19. Makinen H, Kautiainen H, Hannonen P., Mottonen T, Leirisalo-Repo M, Laasonen L, et al. Sustained remission and reduced radiographic progression with combination disease modifying antirheumatic drugs in early rheumatoid arthritis. J Rheumatol 2007; 34:316-21.
20. Levine M, Walter S, Lee H., Haines T, Holbrook A, Moyer V. Users' guides to the medical literature. IV. How to use an article about harm. Evidence-Based Medicine Working Group. JAMA 1994; 271:1615-9.